retatrutide triple agonist glp-1 gip glucagon phase 2 obesity results Retatrutide, a GIP, and receptor agonist Retatrutide is a next-generation triple-pathway
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2























